Open AccessDiscovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET
Author(s) -
Joost Neijssen,
Rosa M.F. Cardoso,
Kristen Chevalier,
Luus Wiegman,
Thomas Valerius,
Geoffrey M. Anderson,
Sheri L. Moores,
Janine Schuurman,
Paul W.H.I. Parren,
William R. Strohl,
Mark L. Chiu
Publication year - 2021
Publication title -
journal of biological chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.361
H-Index - 513
eISSN - 1067-8816
pISSN - 0021-9258
DOI - 10.1016/j.jbc.2021.100641
Subject(s) - epidermal growth factor receptor , hepatocyte growth factor , cancer research , bispecific antibody , monoclonal antibody , egfr inhibitors , cetuximab , epitope , antibody , chemistry , hepatocyte growth factor receptor , small molecule , growth factor receptor , erbb3 , receptor , c met , biology , immunology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom